Efforts underway to improve growth prospects for key markets

Company
10 Jan 2024
5 Min read 
  • Zydus Lifesciences is focusing on growth in key markets and niche portfolios.
  •  Efforts are being made to enhance brand franchise and expand in emerging markets.
  •  The company has a promising product pipeline for significant growth in the US market.
  •  FY25 earnings forecast raised by 5% due to niche launches.
  •  Expected strong YoY earnings growth in FY24 but modest growth in FY25.
  •  Valued at 20x forward earnings with a price target of INR710.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority

Click here to see your activities